Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros












Intervalo de año de publicación
1.
Am J Trop Med Hyg ; 110(4): 669-676, 2024 Apr 03.
Artículo en Inglés | MEDLINE | ID: mdl-38412539

RESUMEN

Chagas disease (CD) is caused by the protozoan Trypanosoma cruzi, which leads to a spectrum of clinical presentations that range from asymptomatic to severe cardiac involvement. The host immune response plays a pivotal role in disease progression. Ig isotypes may contribute to disease pathogenesis. Investigating these components can provide insights into the immunopathogenic mechanisms underlying CD. This cross-sectional study aims to establish a correlation between the Ig profile of individuals infected with T. cruzi with the clinical forms of chronic CD. Serum samples were collected from partner institutions in different states of Brazil. Individuals diagnosed with chronic CD were categorized based on the clinical form of the disease. The indirect ELISA method using the recombinant chimeric Molecular Biology Institute of Paraná membrane protein 8.4 as the antigen was used to determine the Ig profile, including total IgG, IgG1, IgG2, IgG3, and IgG4. Ninety-seven serum samples from patients classified as negative (NEG, n = 38), indeterminate (IND, n = 24), mild cardiac (MC, n = 20), and severe cardiac (SC, n = 15) forms were analyzed. IgG1 exhibited greater levels compared with the other isotypes, showing a significant difference between the MC and IND groups. IgG3 levels were greater in individuals from the MC group compared with the SC group. IgG1 and IgG3 isotypes can serve as biomarkers to evaluate the progression of CD because they exhibit variations across clinical groups. Additional longitudinal studies are necessary to explore the relationship between antibody kinetics and the development of tissue damage.


Asunto(s)
Enfermedad de Chagas , Trypanosoma cruzi , Humanos , Trypanosoma cruzi/genética , Proteínas Recombinantes de Fusión , Estudios Transversales , Antígenos de Protozoos , Enfermedad de Chagas/diagnóstico , Inmunoglobulina G , Anticuerpos Antiprotozoarios
2.
Artículo en Inglés, Portugués | LILACS, BDENF | ID: biblio-1358295

RESUMEN

Objetivo: compreender as principais complicações ocasionadas pelo vírus SARS-CoV-2 no sistema cardíaco do público idoso. Métodos: trata-se de uma revisão sistemática da literatura de abordagem qualitativa e característica descritivo-exploratória realizada no ano de 2020. Resultados: as complicações cardíacas mais prevalentes na população idosa foram miocardite, arritmias, insuficiência cardíaca, infarto agudo, choque cardiogênico, lesão miocárdica aguda e parada cardiorrespiratória. O principal biomarcador cardíaco foi a troponina, apresentando elevação superior ao percentil 99°, evidenciando a necessidade de tratamento em Unidade de Terapia Intensiva. Considerações Finais: o aparecimento desse vírus causou grande prejuízo no campo da saúde, especialmente a população idosa, que apresenta risco elevado de óbito ao contrair essa doença. Destarte, é de extrema importância se ater a mensuração da troponina sérica no público alvo e realizar monitorização longitudinal, utilizando para tal a telecardiologia, uma vez que diminuem as chances de contaminação entre infectado e profissional de saúde


Objective: to understand the main complications of SARS-CoV-2 in the elderly cardiac system. Methods: systematic literature review conducted in 2020. Results: the most prevalent cardiac complications in the elderly population were myocarditis, arrhythmias, heart failure, acute infarction, cardiogenic shock, acute myocardial injury and cardiorespiratory arrest. The main cardiac biomarker was troponin, showing an elevation above the 99th percentile, evidencing the need for treatment in the Intensive Care Unit. Final Considerations: the appearance of this virus has caused great damage in the health field, especially the elderly population, who is at high risk of death when contracting this disease. Therefore, it is important to stick to the measurement of serum troponin in the target audience and perform longitudinal monitoring, using telecardiology for this purpose, since they reduce the chances of contamination between infected and health professionals


Objetivo: comprender las principales complicaciones del SARS-CoV-2 en el sistema cardíaco anciano. Métodos: revisión sistemática de la literatura realizada en 2020. Resultados: las complicaciones cardíacas más prevalentes en la población anciana fueron miocarditis, arritmias, insuficiencia cardíaca, infarto agudo, shock cardiogénico, lesión miocárdica aguda y parada cardiorrespiratoria. El principal biomarcador cardíaco fue la troponina, mostrando una elevación por encima del percentil 99, evidenciando la necesidad de tratamiento en la Unidad de Cuidados Intensivos. Consideraciones finales: la aparición de este virus ha provocado un gran daño en el campo de la salud, especialmente en la población anciana, que se encuentra en alto riesgo de muerte al contraer esta enfermedad. Por tanto, es importante ceñirse a la medición de troponina sérica en el público objetivo y realizar un seguimiento longitudinal, utilizando para ello la telecardiología, ya que reducen las posibilidades de contaminación entre los infectados y los profesionales sanitarios


Asunto(s)
Humanos , Masculino , Femenino , Persona de Mediana Edad , Anciano , Anciano de 80 o más Años , Troponina , Salud del Anciano , COVID-19/complicaciones , Cardiopatías/etiología , Grupo de Atención al Paciente , Choque Cardiogénico , Telecardiología , Paro Cardíaco , Insuficiencia Cardíaca , Unidades de Cuidados Intensivos , Miocarditis
3.
Salvador; s.n; 2013. 73 p. ilus, tab.
Tesis en Portugués | LILACS | ID: biblio-1000905

RESUMEN

A doença de Chagas (DC) é causada pelo protozoário hemoflagelado Trypanosoma cruzi. Estima-se que ainda existam 10 milhões de pessoas infectadas na América Latina. Para a quimioterapia específica da DC o benzonidazol (BZ) é o medicamento de escolha. A eficácia terapêutica dos compostos atualmente em uso clínico tem sido questionada, tendo em conta os diferentes índices de cura já registrados na literatura. A associação do BZ, com medicamentos que apresentem um efeito anti-T. cruzi poderá potencializar a ação antiparasitária do mesmo e possivelmente permitirá o uso de doses menores e consequentemente diminuição dos efeitos tóxicos. O objetivo da presente investigação é avaliar o efeito do tratamento com o BZ associado aos medicamentos nifurtimox (NF) e cetoconazol (CETO)...


Chagas’disease (CD) is caused by the hemoflagelate protozoa Trypanosoma cruzi. It is estimated that 10 million infected people are still living in Latin America. For the specific chemotherapy of CD, the Benznidazole (BZ) is the drug of choice. However, the therapeutic efficacy of the compounds now in clinical use is not confirmed, taking into account that different cure rates have been registered. It is possible that the association of BZ with other drugs with an anti-T. cruzi action could improve its anti-parasitic effect, with the use of lower dose and consequent decrease of the toxic effects. The objective of the present investigation is to evaluate the effect of the treatment with BZ in association with the drugs Nifurtimox (NF) and Ketoconazole (CETO)...


Asunto(s)
Ratones , Enfermedad de Chagas/diagnóstico , Enfermedad de Chagas/mortalidad , Enfermedad de Chagas/patología , Enfermedad de Chagas/prevención & control , Enfermedad de Chagas/transmisión , Quimioterapia/métodos , Quimioterapia , Trypanosoma cruzi , Trypanosoma cruzi/parasitología
4.
Mem. Inst. Oswaldo Cruz ; 106(8): 948-956, Dec. 2011. ilus, graf, tab
Artículo en Inglés | LILACS | ID: lil-610969

RESUMEN

We examined strains of Trypanosoma cruzi isolated from patients with acute Chagas disease that had been acquired by oral transmission in the state of Santa Catarina, Brazil (2005) and two isolates that had been obtained from a marsupial (Didelphis aurita) and a vector (Triatoma tibiamaculata). These strains were characterised through their biological behaviour and isoenzymic profiles and genotyped according to the new Taxonomy Consensus (2009) based on the discrete typing unities, that is, T. cruzi genotypes I-VI. All strains exhibited the biological behaviour of biodeme type II. In six isolates, late peaks of parasitaemia, beyond the 20th day, suggested a double infection with biodemes II + III. Isoenzymes revealed Z2 or mixed Z1 and Z2 profiles. Genotyping was performed using three polymorphic genes (cytochrome oxidase II, spliced leader intergenic region and 24Sα rRNA) and the restriction fragment length polymorphism of the kDNA minicircles. Based on these markers, all but four isolates were characterised as T. cruzi II genotypes. Four mixed populations were identified: SC90, SC93 and SC97 (T. cruzi I + T. cruzi II) and SC95 (T. cruzi I + T. cruzi VI). Comparison of the results obtained by different methods was essential for the correct identification of the mixed populations and major lineages involved indicating that characterisation by different methods can provide new insights into the relationship between phenotypic and genotypic aspects of parasite behaviour.


Asunto(s)
Animales , Humanos , Enfermedad de Chagas/parasitología , Trypanosoma cruzi/genética , Brasil/epidemiología , Consenso , Enfermedad de Chagas/epidemiología , Enfermedad de Chagas/transmisión , Brotes de Enfermedades , ADN Protozoario/genética , Didelphis/parasitología , Reservorios de Enfermedades/parasitología , Genotipo , Insectos Vectores/parasitología , ARN Ribosómico/genética , Triatoma/parasitología , Trypanosoma cruzi/clasificación , Trypanosoma cruzi/patogenicidad
5.
Mem Inst Oswaldo Cruz ; 106(8): 948-56, 2011 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-22241116

RESUMEN

We examined strains of Trypanosoma cruzi isolated from patients with acute Chagas disease that had been acquired by oral transmission in the state of Santa Catarina, Brazil (2005) and two isolates that had been obtained from a marsupial (Didelphis aurita) and a vector (Triatoma tibiamaculata). These strains were characterised through their biological behaviour and isoenzymic profiles and genotyped according to the new Taxonomy Consensus (2009) based on the discrete typing unities, that is, T. cruzi genotypes I-VI. All strains exhibited the biological behaviour of biodeme type II. In six isolates, late peaks of parasitaemia, beyond the 20th day, suggested a double infection with biodemes II + III. Isoenzymes revealed Z2 or mixed Z1 and Z2 profiles. Genotyping was performed using three polymorphic genes (cytochrome oxidase II, spliced leader intergenic region and 24Sα rRNA) and the restriction fragment length polymorphism of the kDNA minicircles. Based on these markers, all but four isolates were characterised as T. cruzi II genotypes. Four mixed populations were identified: SC90, SC93 and SC97 (T. cruzi I + T. cruzi II) and SC95 (T. cruzi I + T. cruzi VI). Comparison of the results obtained by different methods was essential for the correct identification of the mixed populations and major lineages involved indicating that characterisation by different methods can provide new insights into the relationship between phenotypic and genotypic aspects of parasite behaviour.


Asunto(s)
Enfermedad de Chagas/parasitología , Trypanosoma cruzi/genética , Animales , Brasil/epidemiología , Enfermedad de Chagas/epidemiología , Enfermedad de Chagas/transmisión , Consenso , ADN Protozoario/genética , Didelphis/parasitología , Brotes de Enfermedades , Reservorios de Enfermedades/parasitología , Genotipo , Humanos , Insectos Vectores/parasitología , ARN Ribosómico/genética , Triatoma/parasitología , Trypanosoma cruzi/clasificación , Trypanosoma cruzi/patogenicidad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...